Clover Health Investments Corp (DE:7QD)

NASDAQ:7QD

7QD

Clover Health Investments

RESEARCH TOOLSreports

Clover Health Investments (7QD) Price & Analysis

0 Followers

7QD Stock Chart & Stats

€1.79

€0.23(7.23%)

At close: Jan 08 4:00 PM EST

€1.79

€0.23(7.23%)

Day’s Range― - ―

52-Week Range€1.41 - €3.59

Previous CloseN/A

Volume0.00

Average Volume (3M)592.00

Market Cap

€1.79B

Enterprise Value€1.89B

Total Cash (Recent Filing)€177.56M

Total Debt (Recent Filing)€0.00

Price to Earnings (P/E)―

Beta0.72

Next Earnings

Aug 10, 2026

EPS Estimate

0.03

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.11

Shares Outstanding430,969,400

10 Day Avg. Volume404

30 Day Avg. Volume592

Financial Highlights & Ratios

PEG Ratio-0.15

Price to Book (P/B)3.94

Price to Sales (P/S)0.63

P/FCF Ratio-17.62

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€3.62

Price Target Upside102.12% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)0.03

Revenue Forecast (FY)€2.50B

Bulls Say, Bears Say

Bulls Say

Membership GrowthSustained ~51% YoY membership expansion increases scale in core MA markets, improving risk pool diversification and underwriting leverage. Larger membership supports fixed-cost absorption, stronger provider contracting and cohort-driven margin improvement as care-management programs mature.

Balance Sheet StrengthA cash-rich, essentially debt-free balance sheet provides durable financial flexibility to fund growth, invest in care programs and absorb reserve variability. This lowers refinancing risk, supports self-funded expansion of Clover Care, and underpins multi-year operating plans without external capital reliance.

Tech Platform Adoption (Clover Assistant)Growing Clover Assistant penetration embeds clinical workflows and data feedback loops that can sustainably lower medical costs and drive differentiation. Platform adoption creates recurring SaaS revenue optionality and competitive moat through proprietary encounter data and AI-driven care management.

Bears Say

Residual Negative ProfitabilityDespite recent GAAP profitability in a quarter, trailing results show persistent negative net margin. Continued reliance on cohort maturation and cost-management to reach stable profits means earnings durability is uncertain and requires sustained execution to convert scale into consistent bottom-line returns.

Elevated Outpatient Utilization & Part D RisksStructural pressures from higher outpatient utilization and evolving Part D/risk-adjustment rules can erode medical loss ratios over multiple quarters. These trends affect CMS payments and claims costs, making margin assumptions and cohort economics sensitive to utilization normalization and regulatory outcomes.

Cash-Flow Volatility And SG&A/Reserve VariabilityImproved quarterly cash generation masks volatile free-cash-flow trends and occasional reserve and SG&A one-offs. This variability reduces predictability of capital allocation, makes multi-period planning harder, and increases execution risk as margins rely on consistent claims and cost control.

Clover Health Investments News

Clover Health price target raised to $4.20 from $3.20 at Canaccord

Canaccord analyst Richard Close raised the firm’s price target on Clover Health (CLOV) to $4.20 from $3.20 and...

5d ago

CLOV

Nucor, Clean Energy, Clover, Prudential, DoorDash Insider Shake-Up

Insiders have been trading these 5 stocks: (($NUE)), (($CLNE)), (($CLOV)), (($PRU)) and (($DASH)). Here is a breakdown of...

17d ago

NUE

PRU

Clover Health Highlights Q1 Outlook and Profitability Path

Clover Health Investments ( ($CLOV) ) has provided an announcement. On May 18, 2026, Clover Health published a...

22d ago

CLOV

Clover Health Earnings Call Signals Profitable Growth

Clover Health Investments Corp (($CLOV)) has held its Q1 earnings call. Read on for the main highlights of...

1M ago

CLOV

Clover Health Reaffirmed at Buy as Strong Execution Supports Conservative 2026 Outlook; $3.20 Price Target Maintained

In a report released yesterday, Richard Close from Canaccord Genuity maintained a Buy rating on Clover Health Investments,...

1M ago

CLOV

Clover Health Announces CFO Transition and Reaffirms 2026 Outlook

Clover Health Investments ( ($CLOV) ) just unveiled an update. On March 30, 2026, Clover Health’s board approved...

2M ago

CLOV

Clover Health price target lowered to $3.20 from $3.70 at Canaccord

Canaccord lowered the firm’s price target on Clover Health (CLOV) to $3.20 from $3.70 and keeps a Buy...

3M ago

CLOV

Clover Health’s Counterpart Assistant associated with decrease in flu events

Clover Health’s (CLOV) wholly owned subsidiary Counterpart Health, an AI-powered physician-enablement platform, released a whitepaper which finds that...

3M ago

CLOV

Clover Health Highlights Transparency With Supplemental Earnings Q&A

Clover Health Investments ( ($CLOV) ) just unveiled an update. On March 6, 2026, Clover Health Investments, Corp....

3M ago

CLOV

Clover Health becomes first player live on CMS Aligned Network

Clover Health (CLOV) Investments announced a collaboration enabling Clover Health to be the first payer live on a...

3M ago

CLOV

Clover Health price target lowered to $2.75 from $3 at UBS

UBS analyst Jonathan Yong lowered the firm’s price target on Clover Health (CLOV) to $2.75 from $3 and...

3M ago

CLOV

Clover Health reports Q4 EPS (10c), consensus (5c)

Reports Q4 revenue $487.7M, consensus $467.06M. “Our results in 2025 validate the scalability of our differentiated model, despite...

3M ago

CLOV

Clover Health sees FY26 revenue $2.81B-$2.92B, consensus $2.74B

Sees FY26 adjusted EBITDA $50M-$70M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...

3M ago

CLOV

Clover Health options imply 11.2% move in share price post-earnings

Pre-earnings options volume in Clover Health (CLOV) is normal with calls leading puts 2:1. Implied volatility suggests the...

3M ago

CLOV

7QD FAQ

What was Clover Health Investments Corp’s price range in the past 12 months?

Clover Health Investments Corp lowest stock price was €1.41 and its highest was €3.58 in the past 12 months.

What is Clover Health Investments Corp’s market cap?

Clover Health Investments Corp’s market cap is €1.79B.

When is Clover Health Investments Corp’s upcoming earnings report date?

Clover Health Investments Corp’s upcoming earnings report date is Aug 10, 2026 which is in 62 days.

How were Clover Health Investments Corp’s earnings last quarter?

Clover Health Investments Corp released its earnings results on May 06, 2026. The company reported €0.062 earnings per share for the quarter, beating the consensus estimate of €0.059 by €0.003.

Is Clover Health Investments Corp overvalued?

According to Wall Street analysts Clover Health Investments Corp’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Clover Health Investments Corp pay dividends?

Clover Health Investments Corp does not currently pay dividends.

What is Clover Health Investments Corp’s EPS estimate?

Clover Health Investments Corp’s EPS estimate is 0.03.

How many shares outstanding does Clover Health Investments Corp have?

Clover Health Investments Corp has 430,969,400 shares outstanding.

What happened to Clover Health Investments Corp’s price movement after its last earnings report?

Clover Health Investments Corp reported an EPS of €0.062 in its last earnings report, beating expectations of €0.059. Following the earnings report the stock price went up 11.009%.

Which hedge fund is a major shareholder of Clover Health Investments Corp?

Currently, no hedge funds are holding shares in DE:7QD

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Clover Health Investments Stock Smart Score

Neutral

Fundamentals

Return on Equity

-17.08%

Trailing 12-Months

Asset Growth

19.53%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Clover Health Investments Corp

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

Clover Health Investments (7QD) Earnings & Revenues

Historic Earnings Reports

7QD Company Deck

7QD Earnings Call

Q1 2026

0:00 / 0:00

Earnings Call Sentiment|Positive

The call presented a strong set of operational and financial positives: rapid membership growth (~51% YoY), significant revenue growth (+62% YoY), improved gross profit (+47% YoY), GAAP profitability ($27M) and expanding clinical engagement (Clover Assistant reach and Clover Care enrollment up ~90%). Management acknowledged elevated outpatient utilization, Part D and prior-period reserve variability and one-time SG&A items, but described concrete actions (AI/data, dental cost controls, targeted remediation) and emphasized disciplined monitoring. Given the magnitude and breadth of the favorable metrics and the balance of challenges being described as manageable or being actively addressed, the overall tone is optimistic and confidence-driven while cautious on cohort maturation risks.View all DE:7QD earnings summaries

7QD Stock 12 Month Forecast

Average Price Target

€3.62

▲(102.12% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","1":"€1","2":"€2","3":"€3","4":"€4"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3.617892012,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€3.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.617892012,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€3.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.617892012,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€3.62</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1,2,3,4],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.35,3.370607077846154,3.3912141556923077,3.4118212335384617,3.4324283113846152,3.4530353892307692,3.4736424670769233,3.494249544923077,3.514856622769231,3.535463700615385,3.5560707784615384,3.5766778563076924,3.597284934153846,{"y":3.617892012,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.35,3.370607077846154,3.3912141556923077,3.4118212335384617,3.4324283113846152,3.4530353892307692,3.4736424670769233,3.494249544923077,3.514856622769231,3.535463700615385,3.5560707784615384,3.5766778563076924,3.597284934153846,{"y":3.617892012,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.35,3.370607077846154,3.3912141556923077,3.4118212335384617,3.4324283113846152,3.4530353892307692,3.4736424670769233,3.494249544923077,3.514856622769231,3.535463700615385,3.5560707784615384,3.5766778563076924,3.597284934153846,{"y":3.617892012,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.702,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.304,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.445,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.173,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.547,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.96,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.073,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.042,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.86,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.716,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.475,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.15,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.35,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >